These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27748515)

  • 1. MYD88 mutations can be used to identify malignant pleural effusions in Waldenström macroglobulinaemia.
    Gustine JN; Meid K; Hunter ZR; Xu L; Treon SP; Castillo JJ
    Br J Haematol; 2018 Feb; 180(4):578-581. PubMed ID: 27748515
    [No Abstract]   [Full Text] [Related]  

  • 2. Pleural fluid MYD88 L265P mutation supporting diagnosis and decision to treat extramedullary Waldenstrom's macroglobulinemia: a case report.
    Barnes M; Sharma P; Kumar V; Kaell A; LiPera W
    J Med Case Rep; 2020 Jul; 14(1):98. PubMed ID: 32654665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and prognosis implication of MYD88 L265P mutation in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia.
    Correa JG; Cibeira MT; Tovar N; Isola I; Pedrosa F; Díaz T; Lozano E; Magnano L; Rosiñol L; Bladé J; Fernández de Larrea C
    Br J Haematol; 2017 Dec; 179(5):849-851. PubMed ID: 27605200
    [No Abstract]   [Full Text] [Related]  

  • 4. To select or not to select? The role of B-cell selection in determining the MYD88 mutation status in Waldenström Macroglobulinaemia.
    Gustine J; Meid K; Xu L; Hunter ZR; Castillo JJ; Treon SP
    Br J Haematol; 2017 Mar; 176(5):822-824. PubMed ID: 26936399
    [No Abstract]   [Full Text] [Related]  

  • 5. Improved accuracy of discrimination between IgM multiple myeloma and Waldenström macroglobulinaemia by testing for MYD88 L265P mutations.
    Willenbacher W; Willenbacher E; Brunner A; Manzl C
    Br J Haematol; 2013 Jun; 161(6):902-4. PubMed ID: 23560587
    [No Abstract]   [Full Text] [Related]  

  • 6. Waldenström macroglobulinaemia: the key questions.
    D'Souza A; Ansell S; Reeder C; Gertz MA
    Br J Haematol; 2013 Aug; 162(3):295-303. PubMed ID: 23651417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pathology and genetic background of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia].
    Timár B
    Magy Onkol; 2017 Mar; 61(1):6-11. PubMed ID: 28273183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Durable complete remission after chemotherapy and rituximab in a case of Waldenström's macroglobulinemia with pleuropulmonary involvement.
    Capalbo S; Dargenio M; Delia M; Chiefa A; Diomede D; Napoli A; Ricco R; Liso V
    Ann Hematol; 2005 Sep; 84(9):625-6. PubMed ID: 15915349
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic analysis of Diffuse Large B-cell Lymphoma occurring in cases with antecedent Waldenström Macroglobulinaemia reveals different patterns of clonal evolution.
    Talaulikar D; Biscoe A; Lim JH; Gibson J; Arthur C; Mackinlay N; Saxena K; Cheng YY; Chen VM
    Br J Haematol; 2019 May; 185(4):767-770. PubMed ID: 30338525
    [No Abstract]   [Full Text] [Related]  

  • 10. [Waldenström's macroglobulinemia and its individualized therapy options].
    Szemlaky Z; Mikala G
    Orv Hetil; 2017 Oct; 158(41):1604-1614. PubMed ID: 29025291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYD88 wild-type Waldenstrom Macroglobulinaemia: differential diagnosis, risk of histological transformation, and overall survival.
    Treon SP; Gustine J; Xu L; Manning RJ; Tsakmaklis N; Demos M; Meid K; Guerrera ML; Munshi M; Chan G; Chen J; Kofides A; Patterson CJ; Yang G; Liu X; Severns P; Dubeau T; Hunter ZR; Castillo JJ
    Br J Haematol; 2018 Feb; 180(3):374-380. PubMed ID: 29181840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significances of MYD88
    Meng Q; Cao XX; Li J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):578-582. PubMed ID: 28877839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Myddosome Assembly in Waldenstrom Macroglobulinaemia.
    Liu X; Hunter ZR; Xu L; Chen J; Chen JG; Tsakmaklis N; Patterson CJ; Castillo JJ; Buhrlage S; Gray N; Treon SP; Yang G
    Br J Haematol; 2017 Jun; 177(5):808-813. PubMed ID: 27073043
    [No Abstract]   [Full Text] [Related]  

  • 14. TP53 mutations are associated with mutated MYD88 and CXCR4, and confer an adverse outcome in Waldenström macroglobulinaemia.
    Gustine JN; Tsakmaklis N; Demos MG; Kofides A; Chen JG; Liu X; Munshi M; Guerrera ML; Chan GG; Patterson CJ; Meid K; Dubeau T; Yang G; Hunter ZR; Treon SP; Castillo JJ; Xu L
    Br J Haematol; 2019 Jan; 184(2):242-245. PubMed ID: 30183082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bing-Neel Syndrome with Detectable MYD88 L265P Gene Mutation as a Late Relapse Following Autologous Hematopoietic Stem Cell Transplantation for Waldenström's Macroglobulinemia.
    Kopińska AJ; Helbig G; Koclęga A; Kyrcz-Krzemień S
    Turk J Haematol; 2017 Jun; 34(2):186-187. PubMed ID: 28529201
    [No Abstract]   [Full Text] [Related]  

  • 16. Waldenstrom macroglobulinemia: genetics dictates clinical course.
    Lenz G
    Blood; 2014 May; 123(18):2750-1. PubMed ID: 24786453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new era for Waldenstrom macroglobulinemia: MYD88 L265P.
    Treon SP; Hunter ZR
    Blood; 2013 May; 121(22):4434-6. PubMed ID: 23723443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymphoplasmacytic lymphoma accompanied by transformed diffuse large B-cell lymphoma with the MYD88
    Kida T; Tanimura A; Ono A; Matsui T; Honma K; Fujita J; Maeda T; Shibayama H; Oritani K; Morii E; Kanakura Y
    Rinsho Ketsueki; 2017; 58(2):155-160. PubMed ID: 28321094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYD88 and beyond: novel opportunities for diagnosis, prognosis and treatment in Waldenström's Macroglobulinemia.
    Landgren O; Tageja N
    Leukemia; 2014 Sep; 28(9):1799-803. PubMed ID: 24573383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYD88 L265P mutation analysis is a useful diagnostic adjunct for lymphoplasmacytic lymphoma with pleural effusion.
    Pan ST; Wang RC; Kuo CC; Hsieh YC; Su YZ; Chuang SS
    Pathol Int; 2019 Oct; 69(10):601-607. PubMed ID: 31556196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.